Single-Fraction Radiotherapy for CD30+Lymphoproliferative Disorders

BioMed Research International - United States
doi 10.1155/2015/629587
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Breast Implant-Associated ALCL: A Unique Entity in the Spectrum of CD30+ Lymphoproliferative Disorders

Oncologist
Cancer ResearchMedicineOncology
2013English

Lymphoproliferative Disorders

2019English

SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated With a T-Helper-17 Cytokine Profile

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Endogenous Retroviral Elements, but Not Exogenous Retroviruses, Are Detected in CD30-positive Lymphoproliferative Disorders of the Skin

Carcinogenesis
MedicineCancer Research
2003English

Soluble CD30: A Serum Marker for Epstein-Barr Virus-Associated Lymphoproliferative Diseases

Journal of Medical Virology
VirologyInfectious Diseases
2010English

Update on Therapies for Lymphoproliferative Disorders

Journal of Community and Supportive Oncology
OncologyHematology
2015English

CD30+ Primary Cutaneous Post-Transplant Lymphoproliferative Disorder With Signet-Ring Cell Features

Hematology Reports
Hematology
2016English

CD30 Expression and Proliferative Fraction in Nontransformed Mycosis Fungoides

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2009English

Not Bitten by the Bug: A CD30+ Lymphoproliferative Disorder Masquerading as Arthropod Bites

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy